ArticleBlood2021

Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition.

Neeta Bala Tannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.